Navigation Links
Pneumonia Vaccine Is Keeping Kids Healthier

New shot has cut hospitalizations by more than half, CDC study finds

FRIDAY, Dec. 7 (HealthDay News) -- Among children younger than 2, receiving the pneumococcal vaccine appears to be associated with fewer hospitalizations for pneumonia and reduced health-care expenses, according to a new report from the U.S. Centers for Disease Control and Prevention.

Beginning in 2000, the 7-valent pneumococcal conjugate vaccine (PDV7) became part of the routine immunization schedule for American children, according to background information in a news release about the study.

The vaccine -- which protects against pneumococcal pneumonia, caused by the Streptococcus pneumoniae bacteria -- is recommended for all children aged 2 months to 23 months and children aged 24 months to 59 months who are at increased risk for pneumococcal disease.

Between 2002 and 2005, the number of American children aged 19 months to 35 months receiving three or more doses of the PDV7 vaccine increased from 41 percent to 83 percent.

For this study, the CDC researchers analyzed 1997 to 2004 health records from a database of about 40 large U.S. employers. The findings are published in the December issue of the Archives of Pediatrics & Adolescent Medicine.

"Comparing the rates in 2004 with those in the baseline period of 1997 to 1999 among children younger than two years, hospitalizations due to all-cause pneumonia declined from 11.5 to 5.5 per 1,000 children (52.4 percent decline) and ambulatory (outpatient) visits due to all-cause pneumonia declined from 99.3 to 58.5 per 1,000 children (41.1 percent decline)," the study authors wrote.

"Rates of hospitalization due to pneumococcal pneumonia declined from 0.6 to 0.3 per 1,000 children (57.6 percent decline) and rates of ambulatory visits declined from 1.7 to 0.9 per 1,000 children (46.9 percent decline)," the authors added.

The findings add to growing evidence of the benefits of PCV7 vaccination and suggest the vaccine plays an important role in reducing pneumonia rates and health-care costs, the authors concluded.

More information

Visit the U.S. Centers for Disease Control and Prevention for more about child immunizations.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Dec. 3, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Zinc Helps Elderly Ward Off Pneumonia
2. Heart attacks/pneumonia falls short of national goals
3. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
4. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
5. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
6. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
7. Vaccine Stops Alzheimers Brain Tangles
8. Human Papilloma Virus vaccines may decrease chances of oral cancer
9. U.S. Teens Fall Short on Vaccine Coverage
10. Nasal Anthrax Vaccine Proves Effective in Animal Study
11. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: